BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16965359)

  • 1. Systemic and mucosal immunity to respiratory syncytial virus induced by recombinant Streptococcus gordonii surface-displaying a domain of viral glycoprotein G.
    Falcone V; Mihm D; Neumann-Haefelin D; Costa C; Nguyen T; Pozzi G; Ricci S
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):116-22. PubMed ID: 16965359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
    Huang Y; Cyr SL; Burt DS; Anderson R
    J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
    Stott EJ; Taylor G; Ball LA; Anderson K; Young KK; King AM; Wertz GW
    J Virol; 1987 Dec; 61(12):3855-61. PubMed ID: 3316707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response.
    Fan CF; Mei XG
    Vaccine; 2005 Aug; 23(35):4453-61. PubMed ID: 15935522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
    Valosky J; Hishiki H; Zaoutis TE; Coffin SE
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
    Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
    Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis spike glycoprotein and analysis of immunogenicity].
    Tang LJ; Ou D; Ge JW; Xu YG; Li YJ; Shi D; Xia CL; Yu Y
    Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):340-4. PubMed ID: 17552246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
    Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of BALB/c mice by intragastric delivery of Streptococcus gordonii-expressing Giardia cyst wall protein 2 decreases cyst shedding in challenged mice.
    Lee P; Faubert GM
    FEMS Microbiol Lett; 2006 Dec; 265(2):225-36. PubMed ID: 17081198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
    McBurney SP; Young KR; Ross TM
    Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprophylaxis of respiratory syncytial virus infection in the infant ferret.
    Suffin SC; Prince GA; Muck KB; Porter DD
    J Immunol; 1979 Jul; 123(1):10-4. PubMed ID: 448139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein.
    Trudel M; Nadon F; Séguin C; Binz H
    Virology; 1991 Dec; 185(2):749-57. PubMed ID: 1720589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit.
    Oien NL; Brideau RJ; Walsh EE; Wathen MW
    Vaccine; 1994 Jun; 12(8):731-5. PubMed ID: 8091852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene-gun delivery induces IgG in the lung.
    Tree JA; Bembridge G; Hou S; Taylor G; Fashola-Stone E; Melero J; Cranage MP
    Vaccine; 2004 Jun; 22(19):2438-43. PubMed ID: 15193407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.